$38 Billion Worldwide Digital Biomanufacturing Industry to 2030 - Players Include 3M, ABB, Cytiva, Siemens, Immersciobio and Sanofi
December 27, 2022 05:23 ET
|
Research and Markets
Dublin, Dec. 27, 2022 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market, by Type, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022-2030" report has been...
Otonomy Announces Change in Stock Exchange Listing
December 22, 2022 07:53 ET
|
Otonomy, Inc.
SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq)...
Single Use Bioprocessing Global Market Report 2022: Featuring GE Healthcare, Merck, Thermo Fisher Scientific, JM BioConnect & More
December 22, 2022 06:58 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Single Use Bioprocessing Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.The global...
Lilly and ProQR to Expand RNA Editing Collaboration
December 22, 2022 06:00 ET
|
ProQR Therapeutics N.V.
INDIANAPOLIS; LEIDEN, Netherlands; and CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics N.V. (Nasdaq: PRQR), today announced the expansion...
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
December 21, 2022 16:15 ET
|
Madrigal Pharmaceuticals, Inc.
$259 Million in Equity Securities Sales and $50 Million in Additional Debt Financing CapacityMadrigal intends to submit a new drug application for resmetirom in the first half of 2023 CONSHOHOCKEN,...
UAT Group’s Subsidiary, H2O Processing, Enters into Agreement to Acquire Discharge Well Interest Valued at $2.8M Annually
December 21, 2022 07:45 ET
|
Umbra Applied Technologies Group, Inc.
Denver, CO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc’s (OTC Pink: UATG) subsidiary, H2O Processing, announced today that it has entered into an agreement with Bellows...
Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity
December 20, 2022 19:01 ET
|
Sosei Group Corporation
PF-07081532 is the first clinical candidate from multi-target drug discovery collaboration to advance into Phase 2 trialsDosing of first subject in Phase 2 trial by Pfizer triggers payment of US$10...
Mathias Romacker Selected as the Newest Member of the Kymanox Executive Advisor Team
December 20, 2022 11:36 ET
|
Kymanox
Los Angeles, California, USA and Research Triangle Park, North Carolina, USA, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services organization supporting...
Sosei Heptares to present at 41st Annual J.P. Morgan Healthcare Conference
December 20, 2022 01:30 ET
|
Sosei Group Corporation
TOKYO and CAMBRIDGE, United Kingdom, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565) announces its President & CEO Chris Cargill will present at the 41st...
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors
December 19, 2022 16:05 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...